Monday, Feb 12, 2024 · SEC filings

What the smart money revealed on Feb 12

Real insider buys34insiders · $5.05M
Real insider sales99insiders · $165M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

882 insider filings came in. We hid 67 planned (10b5-1) sellers and 655 people whose filings were routine, like grants and tax withholding.

group

4 insiders at Everest Group (EG) bought $948K of stock

Roles: CEO, CFO, COO. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Feb 9
$948K
group

3 insiders at Mercury Systems (MRCY) bought $396K of stock

Roles: CFO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Feb 9
$396K
trending_up

VF (VFC) President and Chief Exec Officer Bracken Darrell bought $1.01M

65,360 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 4 beat Traded Feb 9
$1.01M
trending_up

Rockwell Automation (ROK) President and CEO Blake Moret bought $993K

3,500 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Feb 12
$993K
trending_up

Hillenbrand (HI) Sr. VP Robert VanHimbergen bought $512K

11,319 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 5 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 5 beat Traded Feb 9
$512K
trending_up

Vestis (VSTS) President and CEO Kim Scott bought $287K

15,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Feb 9
$287K
trending_down

Zurn Elkay Water Solutions (ZWS) Chairman and CEO Todd Adams sold $13.2M

Not marked as a planned 10b5-1 sale. Sold 9% of the shares they held directly. Still holds 3.97M shares.

Real sale Form 4 Traded Feb 8–9
$13.2M
trending_down

nVent Electric (NVT) CEO Beth Wozniak sold $12.7M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 342 shares directly.

Real sale Form 4 Traded Feb 8
$12.7M
trending_down

Sl Green Realty (SLG) Director Carol Brown sold $227K

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Feb 9
$227K
Show 23 more real buys
LNC Lincoln National · Director Owen Ryan · Traded Feb 9
$259K
HI Hillenbrand · President and CEO Kimberly Ryan · Traded Feb 9
$252K
SHBI Shore Bancshares · Director David Jones · Traded Feb 8–9
$110K
TGI Triumph Group · Director Neal Keating · Traded Feb 9
$105K
LUMN Lumen Technologies · Director James Fowler · Traded Feb 9
$45K
RRBI Red River Bancshares · Director Michael Brown · Traded Feb 9
$32.7K
EMBC Embecta · Director David Melcher · Traded Feb 12
$32.5K
BSBK Bogota Financial · Director John Masterson · Traded Feb 8
$12.2K
CALX Calix · President and CEO Michael Weening · Traded Aug 14 · Filed late
$11.9K
VRNS Varonis Systems · Director Avrohom Kess · Traded Feb 12
$11.9K
BFIN BankFinancial · Director Aaron O'Connor · Traded Feb 8
$10.4K
FMBM F&M Bank · Director John Willingham · Traded Feb 12
$9.25K
THFF First Financial · Director Susan Jensen · Traded Feb 7
$3.52K
ADMQ ADM Endeavors · CEO Marc Johnson · Traded Feb 9–12
$3.1K
MMLP Martin Midstream Partners · President and CEO Robert Bondurant · Traded Feb 9
$2.84K
SBFM Sunshine Biopharma · CEO Steve Slilaty · Traded Feb 8
$2K
MMLP Martin Midstream Partners · Director Ruben Martin · Traded Feb 9
$1.45K
RGCO RGC Resources · Director Robert Johnston · Traded Feb 8
$1.39K
MMLP Martin Midstream Partners · Executive Vice President / CFO Sharon Taylor · Traded Feb 9
$703
Fundrise Income Real Estate Fund · Director Gayle Starr · Traded Feb 9
$401
MMLP Martin Midstream Partners · Senior VP Operations Scot Shoup · Traded Feb 9
$311
Fundrise Real Estate Interval Fund · Director Gayle Starr · Traded Feb 9
$99
RCG RENN Fund · President and CEO Murray Stahl · Traded Feb 9
$90
Show 96 more real sales
NVT nVent Electric · Director Randall Hogan · Traded Feb 9
$11.8M
JNJ Johnson & Johnson · EVP Jennifer Taubert · Traded Feb 9
$9.28M
GWW W.W. Grainger · Sr. VP and CFO Deidra Merriwether · Traded Feb 8
$7.89M
CSL Carlisle Companies · Exec VP Scott Selbach · Traded Feb 8
$7.68M
VRNS Varonis Systems · EVP Engineering and CTO David Bass · Traded Feb 8–9
$6.56M
NFLX Netflix · Director Jay Hoag · Traded Feb 8
$4.99M
TSCO Tractor Supply · President and CEO Harry Lawton III · Traded Feb 8
$4.78M
REGN Regeneron Pharmaceuticals · SVP Finance and CFO Christopher Fenimore · Traded Feb 9
$4.69M
ZWS Zurn Elkay Water Solutions · SVP and CFO Mark Peterson · Traded Feb 8–9
$4.67M
WFRD Weatherford International · EVP Scott Weatherholt · Traded Feb 8
$4M
SIRI Sirius XM · Director James Meyer · Traded Feb 9
$3.94M
PCAR Paccar · President and CFO Harrie Schippers · Traded Feb 12
$3.48M
SYK Stryker · VP Glenn Boehnlein · Traded Feb 9
$3.29M
PSX Phillips 66 · EVP Richard Harbison · Traded Feb 12
$3.21M
CSL Carlisle Companies · V. P. Lori Snyder · Traded Feb 8
$3.02M
ENPH Enphase Energy · Director Richard Mora · Traded Feb 9
$2.93M
AJG Arthur J. Gallagher · Vice President Thomas Gallagher · Traded Feb 8
$2.93M
AME Ametek · Chief Administrative Officer Ronald Oscher · Traded Feb 9
$2.73M
WFRD Weatherford International · Director Neal Goldman · Traded Feb 8–9
$2.45M
ACLX Arcellx · President Rami Elghandour · Traded Feb 8–12
$2.41M
AXP American Express · Chief Colleague Experience Off Monique Herena · Traded Feb 8
$2.34M
WFRD Weatherford International · Director Benjamin Duster · Traded Feb 9–12
$2.33M
TRV Travelers Companies · EVP and Chief Admin Officer Andy Bessette · Traded Feb 9
$2.15M
CSL Carlisle Companies · President John Berlin · Traded Feb 8
$2.13M
MRK Merck · Executive VP and President Dean Li · Traded Feb 9
$1.85M
TEAM Atlassian · Co-CEO Michael Cannon-Brookes · Traded Feb 9
$1.8M
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Feb 9
$1.8M
TSCO Tractor Supply · EVP Chief Merchandise Officer Jonathan Estep · Traded Feb 8
$1.65M
WTW Willis Towers Watson · Head of Risk and Broking Adam Garrard · Traded Feb 8
$1.46M
CSL Carlisle Companies · President Stephen Schwar · Traded Feb 8
$1.36M
FTV Fortive · VP - Chief Accounting Officer Christopher Mulhall · Traded Feb 9
$1.24M
BWA BorgWarner · EVP Tonit Calaway · Traded Feb 12
$1.14M
XYL Xylem · SVP Claudia Toussaint · Traded Feb 8
$1.1M
SAIA Saia · Exec. VP and Chief Customer Off. Raymond Ramu · Traded Feb 9
$1.1M
WFRD Weatherford International · SVP and Chief Accounting Officer Desmond Mills · Traded Feb 8
$1.08M
EW Edwards Lifesciences · SVP Robert Sellers · Traded Feb 12
$1.06M
COST Costco Wholesale · Director Susan Decker · Traded Feb 9
$1.04M
ZWS Zurn Elkay Water Solutions · Director Timothy Jahnke · Traded Feb 8
$993K
ENVA Enova International · CFO Steven Cunningham · Traded Feb 9
$985K
REGN Regeneron Pharmaceuticals · Director George Sing · Traded Feb 8–9
$950K
CVCO Cavco Industries · President Matthew Nino · Traded Feb 9
$849K
SAIA Saia · EVP Operations Patrick Sugar · Traded Feb 9
$787K
CHD Church & Dwight · Director Penry Price · Traded Feb 9
$762K
EFOR ASGN · President Randolph Blazer · Traded Feb 9
$731K
WYNN Wynn Resorts · CFO Julie Cameron-Doe · Traded Feb 9
$672K
ACLX Arcellx · Chief Medical Officer Christopher Heery · Traded Feb 8–12
$640K
HII Huntington Ingalls Industries · Ex VP Jennifer Boykin · Traded Feb 9
$593K
BC Brunswick · E.v.p. GEN Counsel and Secretary Christopher Dekker · Traded Feb 9
$527K
EXPO Exponent · Chief Human Resources Officer Sally Shepard · Traded Feb 16 · Filed late
$511K
WFRD Weatherford International · Director Charles Sledge · Traded Feb 8
$494K
WFRD Weatherford International · Director Jacqueline Mutschler · Traded Feb 9
$484K
OSK Oshkosh · SVP/Chief Information Officer Anupam Khare · Traded Feb 9
$472K
PJT PJT Partners · General Counsel David Travin · Traded Feb 8
$466K
CMCO Columbus McKinnon · Executive VP Finance Gregory Rustowicz · Traded Feb 8
$392K
SXI Standex International · Vice President/CFO/Treasurer Ademir Sarcevic · Traded Feb 9
$375K
ZWS Zurn Elkay Water Solutions · Director Thomas Christopoul · Traded Feb 8
$347K
XYL Xylem · SVP and Pres Franz Cerwinka · Traded Feb 8
$293K
SXI Standex International · CLO Alan Glass · Traded Feb 9
$248K
MHO M/I Homes · Ex. Vice President and CFO Phillip Creek · Traded Feb 9
$242K
NSSC Napco Security Technologies · Senior Vice President Michael Carrieri · Traded Feb 9
$239K
CSL Carlisle Companies · VP David Smith · Traded Feb 8
$237K
SAIA Saia · Director Donna Epps · Traded Feb 9
$226K
PCAR Paccar · Vice President Todd Hubbard · Traded Feb 12
$212K
MSGK Madison Square Garden Sports · President and COO David Hopkinson · Traded Feb 8
$180K
HLVX HilleVax · President and CEO Robert Hershberg · Traded Feb 8
$173K
ALGT Allegiant Travel · Director Gary Ellmer · Traded Feb 12
$158K
EFOR ASGN · Director Marty Kittrell · Traded Feb 9
$142K
HLVX HilleVax · Director Aditya Kohli · Traded Feb 8
$132K
LIN Linde · Senior Vice President Oliver Pfann · Traded Feb 8
$124K
TROW T. Rowe Price Group · Principal Accounting Officer Jessica Hiebler · Traded Feb 9
$122K
BDSX Biodesix · President and CEO Scott Hutton · Traded Feb 9–12
$116K
EFOR ASGN · SVP Jennifer Painter · Traded Feb 9
$103K
WYNN Wynn Resorts · Director Patricia Mulroy · Traded Feb 9
$101K
BOOT Boot Barn · Director Gene Burt · Traded Feb 8
$85K
HLVX HilleVax · Chief Medical Officer Astrid Borkowski · Traded Feb 8
$58.7K
MC Moelis · Principal Accounting Officer Christopher Callesano · Traded Feb 8
$55.7K
HLVX HilleVax · CFO Shane Maltbie · Traded Feb 8
$53.4K
MTRX Matrix Service · VP Chief Bus Dev/Strat Officer Kevin Durkin · Traded Feb 9
$49.6K
BDSX Biodesix · CFO Robin Cowie · Traded Feb 9–12
$33.9K
EQBK Equity Bancshares · EVP Julie Huber · Traded Feb 8
$33.7K
EQBK Equity Bancshares · General Counsel Brett Reber · Traded Feb 8
$30.8K
ZNTL Zentalis Pharmaceuticals · CFO Melissa Epperly · Traded Feb 12
$29.4K
XFOR X4 Pharmaceuticals · CFO Adam Mostafa · Traded Feb 12
$28K
FLWS 1 800 Flowers Com · Chief Information Officer Arnold Leap · Traded Feb 9
$28K
FIGS FIGS · CFO Daniella Turenshine · Traded Feb 8
$25.2K
XFOR X4 Pharmaceuticals · President and CEO Paula Ragan · Traded Feb 12
$21.9K
BDSX Biodesix · Chief Commercial Officer Kieran O'Kane · Traded Feb 9–12
$21.1K
BDSX Biodesix · Chief Development Officer Gary Pestano · Traded Feb 9–12
$19.6K
TVRD Cara Therapeutics · President and CEO Christopher Posner · Traded Feb 8
$18.9K
ZNTL Zentalis Pharmaceuticals · President Cam Gallagher · Traded Feb 12
$13.4K
EQBK Equity Bancshares · Chief Credit Officer Krzysztof Slupkowski · Traded Feb 8
$5.75K
TVRD Cara Therapeutics · Chief Medical Officer Joana Goncalves · Traded Feb 8 · Filed late
$4.12K
TVRD Cara Therapeutics · Sec'y Scott Terrillion · Traded Feb 8 · Filed late
$4.12K
XFOR X4 Pharmaceuticals · COO Mary DiBiase · Traded Feb 12
$3.72K
BDSX Biodesix · Chief Accounting Officer Chris Vazquez · Traded Feb 9–12
$3.6K
XFOR X4 Pharmaceuticals · Chief Scientific Officer Arthur Taveras · Traded Feb 12
$795

13F season

Holdings as of Dec 31, 2023 are due Feb 14

49 funds have filed so far. 40 filed for the quarter before.

Biggest real insider buys, Feb 6–12

Open-market buys by officers and directors, filed in the 7 days up to Feb 12.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist